April 26, 2024 21:18 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court rejects plea seeking 100 pct votes verification on EVMs, rules out returning to ballot papers | Voting concludes in 88 constituencies with 61% turnout by 5 pm | Justice MB Snehalatha takes oath as additional judge of Kerala High Court | NIA arrests key accused in pro-Khalistani attack on Indian Mission in London | Plea filed in Calcutta HC seeking action against Mamata Banerjee's 'judges purchased' remark
Dr. Reddy’s Laboratories announces launch of Russia's Sputnik V vaccine in the Indian market, priced at Rs. 948 Sputnik V
WIKIMEDIA COMMONS

Dr. Reddy’s Laboratories announces launch of Russia's Sputnik V vaccine in the Indian market, priced at Rs. 948

India Blooms News Service | @indiablooms | 14 May 2021, 02:44 pm

Hyderabad: Dr. Reddy’s Laboratories Ltd on Friday announced that the first consignment of imported doses of the Russian Sputnik V vaccine that landed in India on May 1, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13.

As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad today on 14th May, 2021.

Further consignments of imported doses are expected over the upcoming months.Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners.

The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, with the possibility of a lower price point when local supply begins.The Companyis working closely with its six manufacturing partners in India to fulfill regulatory requirements to ensure smooth and timely supply.

Dr. Reddy’s will work closely with stakeholders in the Government and private sector in India to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort. This is a reaffirmation of the Company’s commitment to explore every avenue in the fight against the COVID-19 pandemic in India.

GV Prasad, Co-Chairman and Managing Director, said: “With the rising cases in India, vaccination is our most effective tool in our battle against COVID-19.Contributing to the vaccination drive in Indiais ourbiggest priorityright now to help Indians be healthy and safe.”

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.